Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT00403715 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 500
Last updated 2016-11-29
Summary
The purpose of this trial is to compare the effectiveness and safety of INS365 Ophthalmic Solution with Placebo when applied topically in subjects with dry eye disease.
Conditions
Interventions
- DRUG
-
diquafosol tetrasodium (INS365) Ophthalmic Solution
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Amy Schaberg, BSN
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-02-28
- Primary Completion
- 2002-09-30
- Completion
- 2002-09-30
More Related Trials
-
The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)
NCT00831662 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634)
NCT00600288 ·Status: COMPLETED ·Phase: PHASE3
-
Study of SkQ1 as Treatment for Dry-eye Syndrome
NCT03764735 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome
NCT01670357 ·Status: COMPLETED ·Phase: PHASE2
-
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01118754 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes
NCT03846453 ·Status: COMPLETED ·Phase: PHASE3
-
Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01101984 ·Status: COMPLETED ·Phase: NA
-
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01468168 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants
NCT05992922 ·Status: TERMINATED ·Phase: PHASE2
-
A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease
NCT03404115 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease
NCT00758784 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease
NCT05238597 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of TOP1630 for Dry Eye Syndrome
NCT03088605 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group
NCT01768312 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye
NCT00799552 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease
NCT04735393 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Rebamipide Eye Drops to Treat Dry Eye
NCT00201955 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of RX-10045 in the Treatment of Dry Eye Disease
NCT01675570 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
NCT02254265 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease
NCT06766357 ·Status: RECRUITING ·Phase: PHASE3
-
The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease
NCT04674358 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study
NCT04884217 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of CKD-352
NCT04548427 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of CF101 to Treat Patients With Dry Eye Disease
NCT01235234 ·Status: COMPLETED ·Phase: PHASE3